Lonza raddoppia la produzione di vaccini – Intervista al Presidente di FIT Giorgio Calderari 30 April 2021
Helsinn Announces the Launch of Adlumiz® (anamorelin) for the Treatment of Cancer Cachexia in Japan 21 April 2021
Helsinn announces poster presentation at Academy of Managed Care Pharmacy (AMCP)2021 Virtual Meeting evaluating healthcare resource utilization in CINV 13 April 2021
BridgeBio Pharma’s Affiliate QED Therapeutics and Helsinn Group Announce Strategic Collaboration to Co-Develop and Commercialize Infigratinib in Oncology 31 March 2021
“Banche e industria, un binomio vincente nella crisi pandemica”– Tavola rotonda online, ospite il presidente di FIT Giorgio Calderari 25 March 2021
Corriere del Ticino “La crisi si può superare solo con il gioco di squadra” Tavola rotonda Abt, ospite il presidente di FIT, Giorgio Calderari 25 March 2021
La Regione “Covid, un’economia comunque resiliente” Tavola rotonda Abt, ospite il presidente di Farma Industria Ticino, Giorgio Calderari 25 March 2021
Taiho Pharmaceutical Submits New Drug Application for NK1 Receptor Antagonist Fosnetupitant for Prevention of Gastrointestinal Symptoms (Nausea and Vomiting) Associated with Cancer Chemotherapy 23 March 2021
Linkedin